You may be surprised about how much you can make from selling the intellectual property of a failed company, say John Cronin and John Ciannamea of ipCapital Group
6 min read · 01 July 2010
NVCA and Spencer Stuart discuss the results of their survey of more than 200 NVCA members
6 min read · 01 July 2010
The competitive drive of VCs was in full gear, as investors and staffers from 10 venture firms competed in the Silicon Valley International Triathlon, which featured a 1,500-meter swim, a 24.9-mile bike ride and a 6.2-mile run
3 min read · 01 July 2010
Female business angels make up a fraction of the market, but they are spreading their wings and finding promising startups that their male counterparts have overlooked
6 min read · 01 July 2010
1 min read · 01 July 2010
Sirion Therapeutics Inc. has sold the assets and U.S. rights for Zirgan, a topical anti-viral for the treatment of corneal ulcers, to Bausch + Lomb. No financial terms were disclosed. Sirion is a Tampa, Fla.-based drug company focused on ophthalmic products. It has raised over $45 million in VC funding from Aisling Capital, Investor Growth Capital, Atlas Venture, Advent International, Bear Sterns Healthcare Value Partners and NovaQuest.
3 min read · 08 June 2010
1 min read · 01 June 2010
Mn Services’ Jos van Gisbergen is still a fan of venture capital, but he is very selective about the teams he backs
9 min read · 01 June 2010
News about HarbourVest, the U.K. Pension Protection Fund, the Brenninkmeijer Family Office, and AlpInvest backer PGGM Investments
5 min read · 01 June 2010
Seven VC-backed companies went public in April: Alimera Sciences, Alpha & Omega Semiconductor, Codexis, Convio, Global Geophysical Services, SPS Commerce and Tengion
8 min read · 01 June 2010